Loading…
H.R. 3037119th CongressIn committeeLatest action Apr 28, 2025Decoded by AI · checked against the record
Official title: Access to Breast Cancer Diagnosis Act of 2025
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
HR 3037 bans deductibles and copays for diagnostic and supplemental breast exams starting January 1, 2026.
50-second read · 5 questions answered below
HR 3037 would require health insurance plans to cover diagnostic and supplemental breast exams with no deductibles, copays, or coinsurance charged to patients. Covered exams include MRIs, ultrasounds, and diagnostic mammograms. The requirement would take effect for plan years beginning January 1, 2026.
The bill affects people who need follow-up breast imaging after an abnormal screening result or who are recommended extra screening due to elevated personal risk. It applies to most private health insurance, including job-based group plans, individual plans, grandfathered plans, and high-deductible health plans linked to Health Savings Accounts.
Currently, diagnostic and supplemental breast exams often carry out-of-pocket costs even when a routine mammogram is fully covered. Insurance companies and employers offering health coverage would be required to absorb those costs rather than passing them to patients.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.